Skip to main content
. 2023 Feb 24;22(1):75–85. doi: 10.2450/BloodTransfus.485

Figure 3.

Figure 3

Change in glucose metabolism between the baseline and follow-up magnetic resonance imaging scans in the three treatment groups

DFP: deferiprone; MRI: magnetic resonance imaging; N: number; NGT: normal glucose tolerance; IFG: impaired fasting glucose; IGT: impaired glucose tolerance; DM: diabetes mellitus; FU: follow-up; DFO: desferrioxamine; DFX: deferasirox.